Literature DB >> 8784107

Nonisotopic single strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency.

O Hiort1, G H Sinnecker, H Willenbring, A Lehners, A Zöllner, D Struve.   

Abstract

5 alpha-Reductase deficiency is a rare autosomal recessive disorder of defective virilization in karyotypic males due to reduced conversion of testosterone to dihydrotestosterone. The gene encoding the affected 5 alpha-reductase type 2 enzyme has recently been cloned, and mutations within the coding region have been discovered as the cause of this disease. We address the possibility of a rapid nonradioactive molecular genetic screening technique for initial diagnosis and report different point mutations in this gene in eight unrelated patients with clinical features of 5 alpha-reductase deficiency. For molecular genetic analysis, DNA from peripheral blood leukocytes was studied. The coding region of the 5 alpha-reductase type 2 gene was characterized by exon-specific PCR amplification, nonradioactive single strand conformation analysis, and direct sequencing. In seven patients, homozygous point mutations were identified (Leu55-Gln, delta Met157, Gly196-Ser, Arg227-Gln, Ala228-Thr, and His231-Arg). One individual was a compound heterozygote carrier of two mutations (Ile112-Asn and Gln126-Arg). We conclude that molecular genetic characterization of point mutations in the 5 alpha-reductase type 2 gene may be used as an additional valuable procedure for the diagnosis of this disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784107     DOI: 10.1210/jcem.81.9.8784107

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  A novel mutation of 5alpha-steroid reductase 2 deficiency (CD 65 ALA-PRO) with severe virilization defect in a Turkish family and difficulty in gender assignment.

Authors:  Senay Savas Erdeve; Zehra Aycan; Merih Berberoglu; Zeynep Siklar; Bulent Hacihamdioglu; Kadir Sipahi; Nejat Akar; Gonul Ocal
Journal:  Eur J Pediatr       Date:  2010-02-24       Impact factor: 3.183

Review 2.  Disorders of sex development: effect of molecular diagnostics.

Authors:  John C Achermann; Sorahia Domenice; Tania A S S Bachega; Mirian Y Nishi; Berenice B Mendonca
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

3.  Molecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population.

Authors:  Meshael M Alswailem; Ohoud S Alzahrani; Lamyaa Alghofaili; Ebtesam Qasem; Mai Almohanaa; Afaf Alsagheir; Bassam Bin Abbas; Najya A Attia; Adnan Al Shaikh; Ali S Alzahrani
Journal:  Endocrine       Date:  2018-09-29       Impact factor: 3.633

4.  Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population.

Authors:  M Rahimi; M Ghanbari; Z Fazeli; M Rouzrokh; S Omrani; R Mirfakhraie; M D Omrani
Journal:  J Endocrinol Invest       Date:  2016-11-15       Impact factor: 4.256

5.  The IVS1-2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency.

Authors:  N Skordis; V Neocleous; A Kyriakou; E Efstathiou; A Sertedaki; P Philibert; L A Phylactou; S Lumbroso; C Sultan
Journal:  J Endocrinol Invest       Date:  2010-05-28       Impact factor: 4.256

6.  Targeted next-generation sequencing identification of mutations in patients with disorders of sex development.

Authors:  Yanling Dong; Yuting Yi; Hong Yao; Ziying Yang; Huamei Hu; Jiucheng Liu; Changxin Gao; Ming Zhang; Liying Zhou; Xin Yi; Zhiqing Liang
Journal:  BMC Med Genet       Date:  2016-03-15       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.